| Revenue growth | Value |
|---|---|
| 1Y (TTM) | -12% |
| 3Y CAGR | 0% |
| Profit growth | Value |
|---|---|
| 1Y (TTM) | -58% |
| 3Y CAGR | -10% |
| Stock | Mkt price (1D) | 52 week performance | Market cap | P/E ratio | P/B ratio | |
|---|---|---|---|---|---|---|
Caplin Point LaboratoriesCAPLIPOINT | ₹2,787.10 +38.50 (1.40%) | 20,886.87 | 30.81 | 6.2 | ||
PfizerPFIZER | ₹4,026.60 +24.20 (0.60%) | 18,304.58 | 24.9 | 4.36 | ||
Jubilant PharmovaJUBLPHARMA | ₹1,068.05 +2.65 (0.25%) | 16,999.70 | 48.37 | 2.4 | ||
Astrazeneca Pharma IndiaASTRAZEN | ₹6,714.00 -37.50 (0.56%) | 16,878.50 | 99.5 | 19.34 |